How does Atorvastatin influence lipid markers in cardiovascular comorbidities, and what are its benefits in managing patients with multiple risk factors?
Sahil KapoorExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Atorvastatin significantly reduces LDL-C, total cholesterol, and triglycerides, while modestly increasing HDL-C, thereby improving overall lipid profiles in patients with cardiovascular risk factors.